Cancer Institute A national cancer institute
designated cancer center

December 2010 Cancer Center Bulletin

Director's Message

Dear Cancer Center members,

Best wishes for the holidays!

Save the dates:

March 25 & 26, 2011
The 12th Multidisciplinary Management of Cancers: A Case-based Approach

Li Ka Shing Center for Learning & Knowledge
2nd Floor Conference Center
This is a unique CME meeting with its emphasis on tumor board cases.
To see the brochure and registration information, visit: http://cancer.stanford.edu/documents/2010CME-CancerBrFinalp4.pdf

April 11, 2011
Stanford Cancer Center Members’ Retreat

Quadrus Conference Center
Details are forthcoming

Important funding opportunities:

Mary Kay Foundation
Cancer Research Grant Program
Limited funding opportunity for Stanford faculty with NTLR-Research, MCL and/or UTL appointments involved in translational research in ovarian, uterine, breast or cervical cancer.
Internal deadline: Wednesday, Dec 15, 2010, 4 pm
Eligibility and submission guidelines: http://med.stanford.edu/rmg/funding/marykay.html

Damon Runyon Cancer Research Foundation
Clinical Investigator Award
Internal deadline: Monday, Jan 31, 2011, 4 pm
Eligibility and submission guidelines: http://med.stanford.edu/rmg/funding/damonrunyonclinical.html

Core Facilities:

One of our major roles is to help provide outstanding core facilities for our members. Please visit the website (http://cancer.stanford.edu/research/core/), or see our new brochure (which is also available at our offices in the Lokey Building, Room 2103B).

 

Kudos:

Andrei Iagaru, MD, has been appointed assistant professor of radiology. His research focuses on the use of whole-body MRI and PET/CT for early cancer detection. He is also interested in nuclear medicine and radioimmunotherapy.

John Ioannidis, MD, DSc, professor of medicine, has been appointed the C.F. Rehnborg Professor in Disease Prevention in the School of Medicine. He recently joined the medical school faculty as the new division chief of the Stanford Prevention Research Center. His work combines skills in clinical research methodology and evidence-based medicine with the challenges of current molecular medicine and genomics. He is focused on strengthening the way that research is planned, carried out and reported. Dr. Ioannidis was recently elected as a fellow of the European Academy of Cancer Sciences, a newly created organization that will provide independent, authoritative and evidence-based advice to underpin policy for the prevention, the management and palliation of cancer in Europe.

Ginna Laport, MD, associate professor of medicine-blood & marrow transplantation, has been elected chair-elect of the National Institutes of Health-funded Blood and Marrow Transplant Clinical Trials Network (BMT CTN).  Dr. Laport is the first female chair in the network’s 10-year history. The BMT CTN is a national consortium of the 16 major academic hematopoietic stem cell transplant centers in the United States. The mission of the BMT CTN is to conduct multicenter trials that advance the field of BMT. The network is funded by a U01 grant from the National Cancer Institute and the National Heart, Lung and Blood Institute.

Michael Levitt, PhD, professor of structural biology, has been appointed the Robert W. and Vivian K. Cahill Professor in Cancer Research in the School of Medicine. Levitt’s work focuses on theoretical, computer-aided analysis of the protein, DNA and RNA molecules responsible for life at it most fundamental level. His early work pioneered computational structural biology discovering how to predict structure, compute structural changes, refine experimental structure, model enzyme catalysis and classify protein structures. His basic research set the stage of most subsequent work in a rapidly growing field. It also led to practical methods for antibody humanization that are key for modern anti-cancer therapy, including Avastin.

Robert W. Cahill, president of the Cahill Investment Co. and a partner in the Cahill Construction Co. for 40 years, was a third-generation San Franciscan with close ties to the Stanford community. Following his death in 1980, his wife Vivian and his three brothers established a fund in his honor for a Cahill Faculty Prize in cancer research at the School of Medicine. In 1991, the family augmented the fund to establish the Robert W. Cahill Professorship in Cancer Research.Vivian and Robert Cahill were both Stanford graduates, as are two of their three children. Robert Cahill’s brothers also attended Stanford. The title of the professorship was changed in 1994 at the family’s request, following Vivian Cahill’s death.

Samuel So, MD, professor of surgery, director of the Asian Liver Center and executive secretary of the Asia and Pacific Alliance to Eliminate Viral Hepatitis, was featured in an article on the global response to viral hepatitis in the Bulletin of the World Health Organization (2010;88:801-802).

Lei Xing, MD, professor of radiation oncology, has been named the Jacob Haimson Professor. Xing’s research focuses on medical imaging and image-guided radiation therapy. He is a world expert in inverse treatment planning, image reconstruction, nanophosphor molecular imaging and real-time image guidance for advanced therapeutic modalities such as volumetric modulated radiation therapy. Xing is director of radiation physics division of the department of radiation oncology.

The professorship was established with a gift from Sarah Donaldson, MD, and Jacob Haimson, DSc, with the intention that the chair holder be the director of the radiation physics program. Donaldson is the Catharine and Howard Avery Professor in the School of Medicine, associate chair of the department of radiation oncology and associate director of the radiation oncology residency training program. Haimson is president of Haimson Research Corp. in Santa Clara, Calif. He is recognized as an international authority in the design of microwave electron linear accelerators.

The Haimson Professorship is the first endowed chair given to a department of radiation oncology specifically intended to be held by a radiation physicist. Upon Donaldson’s retirement from Stanford, the name of the chair will be changed to the Sarah S. Donaldson and Jacob Haimson Professorship.

Please let us know of new grants, honors, and publications so that we can include them in the monthly Bulletin.


Best regards,

Bev

Beverly Mitchell Signature
Beverly S. Mitchell, MD
Director, Stanford Cancer Center

(November 2010 Director's Message)

Posted 12/01/10

Stanford Medicine Resources:

Footer Links: